Diabetes Self-Care Declines During Breast Cancer Treatment
Patients experience reduced monitoring, emotional distress, and gaps in coordinated care during adjuvant therapy
By
Kathryn Wighton
April 15, 2026
Clinical Scorecard: Diabetes Self-Care Declines During Breast Cancer Treatment
At a Glance
Category Detail
Condition Diabetes management challenges during adjuvant breast cancer treatment Key Mechanisms Treatment-related symptoms disrupt diabetes routines; prioritization of cancer care over diabetes; reduced monitoring and emotional distress Target Population Patients with concurrent diabetes undergoing breast cancer treatment Care Setting Oncology and diabetes care settings, including outpatient and virtual care
Key Highlights
Diabetes self-care including diet, physical activity, glucose monitoring, and medication adherence declines during breast cancer treatment. Glycated hemoglobin testing and glycemic control worsen post-cancer diagnosis, with many patients reporting glucose levels exceeding 200 mg/dL. Emotional distress and cancer-related post-traumatic stress significantly impair perceived diabetes control and increase diabetes-related emotional impact. Guideline-Based Recommendations
Diagnosis
Monitor glycated hemoglobin regularly during breast cancer treatment to assess glycemic control. Distinguish symptoms related to cancer treatment from diabetes complications to guide management. Management
Prioritize integrated care coordination between oncology and diabetes clinicians to ensure concurrent management. Consider personalized diabetes care models, such as monthly virtual visits, to reduce diabetes distress and improve treatment satisfaction. Address treatment-related symptoms (fatigue, nausea, appetite loss) that disrupt diabetes self-care routines. Monitoring & Follow-up
Increase frequency of glucose monitoring during cancer treatment to detect and manage hyperglycemia promptly. Implement regular assessment of emotional distress and fatigue to support diabetes self-management. Risks
Reduced diabetes self-care increases risk of poor health outcomes and progression of diabetes-related complications. Cancer-related fatigue and emotional distress exacerbate difficulties in maintaining glycemic control. Patient & Prescribing Data
Patients with breast cancer and pre-existing diabetes undergoing adjuvant treatment
Adherence to diabetes medications declines during cancer treatment; personalized virtual care interventions may improve adherence and reduce distress.
Clinical Best Practices
Ensure clear communication and role delineation between oncology and diabetes care providers. Incorporate routine emotional and symptom burden assessments into diabetes management during cancer treatment. Utilize telehealth or virtual care models to provide ongoing diabetes support during breast cancer therapy. References
